Salbutamol side effects
Pro Research Analysisby 
Searched over 200M research papers
Side Effects of Salbutamol: A Comprehensive Overview
Salbutamol, also known as albuterol, is a widely used beta-2 adrenoceptor agonist primarily prescribed for the treatment of asthma and other reversible obstructive airway diseases. While it is effective in providing rapid bronchodilation, it is also associated with a range of side effects, particularly when administered in higher doses or through certain routes.
Metabolic Side Effects of Salbutamol
Changes in Blood Glucose and Insulin Levels
Salbutamol can cause significant metabolic changes, including increases in plasma glucose and serum insulin levels. These effects are more pronounced with intravenous administration compared to aerosol inhalation Phillips1980Neville1977. This can be particularly concerning for patients with abnormal glucose tolerance, as it may exacerbate hyperglycemia.
Electrolyte Imbalances
Salbutamol administration is associated with decreases in plasma potassium, phosphate, and corticosteroids, leading to conditions such as hypokalemia, hypocalcemia, and hypomagnesemia . These electrolyte imbalances can have serious implications, especially in patients predisposed to such conditions.
Lipid Metabolism
The drug also affects lipid metabolism, causing significant hyperlactatemia and ketonemia, which can be problematic for patients at risk of lactic acidosis .
Cardiovascular Side Effects
Tachycardia and Heart Rate Increases
One of the most common cardiovascular side effects of salbutamol is tachycardia, or an increased heart rate. This effect is dose-dependent and can be observed with both intravenous and inhaled forms of the drug Phillips1980Neville1977Bennett1994.
Blood Pressure Changes
While salbutamol generally does not cause significant changes in blood pressure, it can lead to peripheral vasodilation, particularly in hypoxic conditions. This can result in increased forearm blood flow, which may contribute to the cardiovascular risks associated with the drug .
Sudden Death in Asthmatic Patients
There is an association between the use of beta-2 agonists like salbutamol and sudden death in asthma patients, particularly under hypoxic conditions. This is thought to be due to the detrimental cardiovascular effects exacerbated by hypoxia .
Neuromuscular Side Effects
Tremor
Tremor is a dose-limiting side effect of salbutamol, observed with both oral and inhaled administration. It is more pronounced at higher doses and can be a significant limiting factor in the drug's use Newhouse1994Larsson1977.
Muscle Strength and Endurance
Interestingly, salbutamol has been shown to increase muscle strength and endurance performance in non-asthmatic individuals. However, this effect is accompanied by side effects such as increased plasma lactate and potassium concentrations, which can be problematic .
Route of Administration and Side Effects
Intravenous vs. Aerosol Administration
The route of administration significantly impacts the side effect profile of salbutamol. Intravenous administration is associated with more severe metabolic and cardiovascular side effects compared to aerosol inhalation. For instance, intravenous salbutamol causes significant increases in plasma insulin and glucose levels, as well as a fall in serum potassium concentration, whereas aerosol administration results in only a small transient increase in plasma glucose .
Oral Administration
Oral salbutamol is less efficacious than inhaled forms but still provides significant bronchodilation. However, it is associated with more frequent side effects such as tremor and tachycardia due to higher systemic absorption Price1989Larsson1977.
Conclusion
Salbutamol is an effective bronchodilator with a well-established role in the treatment of asthma and other obstructive airway diseases. However, its use is accompanied by a range of side effects, particularly metabolic and cardiovascular, which are dose-dependent and influenced by the route of administration. Careful consideration and monitoring are required, especially in patients with predisposing conditions such as abnormal glucose tolerance, potassium depletion, or cardiovascular risks.
Sources and full results
Most relevant research papers on this topic